Review Article

Diabetogenic Petroleum Industry-Induced Pollutants in Nigeria’s Niger Delta: Laboratory Diagnostic Challenges for Type 2 Diabetes Management

Abstract

Background: The Niger Delta region of Nigeria experiences chronic environmental pollution driven by oil and gas extraction. Emerging evidence links these industrial pollutants to endocrine disruption, specifically targeting metabolic pathways that lead to Type 2 Diabetes Mellitus (T2DM). Objective: This narrative review synthesizes current knowledge on diabetogenic environmental pollutants from the petroleum sector in the Nigerian Niger Delta and critically evaluates the pre-analytical, analytical, and post-analytical challenges these contaminants impose on T2DM laboratory medicine workflows. Methods: A comprehensive literature search was conducted across major electronic databases for peer-reviewed articles published between 2000 and 2026.  Keywords focused on heavy metals, polycyclic aromatic hydrocarbons (PAHs), volatile organic compounds (VOCs), oil spills, gas flaring, diabetes mellitus, and clinical laboratory services within the Nigerian context. Results: Flaring and oil spills release massive quantities of diabetogenic agents, including heavy PAHs, VOCs, and heavy metals. These pollutants induce metabolic dysfunction through systemic pathways: chronic systemic inflammation, oxidative stress, beta-cell apoptosis, and insulin receptor antagonism. For laboratory medicine workflow, these pollutants create complex diagnostic challenges. They introduce pre-analytical (altering erythropoiesis, hence glycated hemoglobin A1c status), analytical (chemical interferences in assays), and postanalytical (confounding biomarkers of organ failure) challenges to T2DM diagnostics. Conclusion: Environmental diabetogenesis represents an escalating public health crisis in Nigeria’s Niger Delta. To mitigate this threat, clinical laboratories must evolve. There is an urgent need to standardize diagnostic protocols to account for pollutant interference, establish locally adapted biomarker reference intervals, and integrate environmental toxicological monitoring into routine metabolic disease management.